vs
Atlanticus Holdings Corp（ATLCP）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Atlanticus Holdings Corp的季度营收约是Royalty Pharma plc的1.2倍（$734.4M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 4.7%，领先29.7%），Atlanticus Holdings Corp同比增速更快（107.8% vs 4.8%），过去两年Atlanticus Holdings Corp的营收复合增速更高（58.9% vs 4.6%）
Atlanticus Holdings Corp是一家总部位于美国的金融科技及消费金融企业，主要服务美国境内信用记录不足或非优质信用的消费者群体，提供消费分期、个人贷款等普惠信贷产品，同时与零售商户及金融机构合作推出定制化灵活信贷解决方案。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
ATLCP vs RPRX — 直观对比
营收规模更大
ATLCP
是对方的1.2倍
$622.0M
营收增速更快
ATLCP
高出103.0%
4.8%
净利率更高
RPRX
高出29.7%
4.7%
两年增速更快
ATLCP
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $734.4M | $622.0M |
| 净利润 | $34.6M | $214.2M |
| 毛利率 | 92.4% | — |
| 营业利润率 | 6.3% | 62.4% |
| 净利率 | 4.7% | 34.4% |
| 营收同比 | 107.8% | 4.8% |
| 净利润同比 | 11.7% | 2.9% |
| 每股收益（稀释后） | $1.75 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATLCPRPRX
| Q4 25 | $734.4M | $622.0M | ||
| Q3 25 | $494.7M | $609.3M | ||
| Q2 25 | $394.2M | $578.7M | ||
| Q1 25 | $345.2M | $568.2M | ||
| Q4 24 | $353.5M | $593.6M | ||
| Q3 24 | $351.2M | $564.7M | ||
| Q2 24 | $316.0M | $537.3M | ||
| Q1 24 | $290.7M | $568.0M |
净利润ATLCPRPRX
| Q4 25 | $34.6M | $214.2M | ||
| Q3 25 | $25.0M | $288.2M | ||
| Q2 25 | $30.6M | $30.2M | ||
| Q1 25 | $31.5M | $238.3M | ||
| Q4 24 | $31.0M | $208.2M | ||
| Q3 24 | $29.5M | $544.0M | ||
| Q2 24 | $24.3M | $102.0M | ||
| Q1 24 | $26.2M | $4.8M |
毛利率ATLCPRPRX
| Q4 25 | 92.4% | — | ||
| Q3 25 | 92.1% | — | ||
| Q2 25 | 91.4% | — | ||
| Q1 25 | 90.7% | — | ||
| Q4 24 | 89.9% | — | ||
| Q3 24 | 92.0% | — | ||
| Q2 24 | 91.2% | — | ||
| Q1 24 | 90.8% | — |
营业利润率ATLCPRPRX
| Q4 25 | 6.3% | 62.4% | ||
| Q3 25 | 6.6% | 70.1% | ||
| Q2 25 | 10.2% | 36.3% | ||
| Q1 25 | 11.8% | 94.0% | ||
| Q4 24 | 11.3% | 60.9% | ||
| Q3 24 | 10.6% | — | ||
| Q2 24 | 9.1% | 50.2% | ||
| Q1 24 | 11.3% | -13.0% |
净利率ATLCPRPRX
| Q4 25 | 4.7% | 34.4% | ||
| Q3 25 | 5.0% | 47.3% | ||
| Q2 25 | 7.8% | 5.2% | ||
| Q1 25 | 9.1% | 41.9% | ||
| Q4 24 | 8.8% | 35.1% | ||
| Q3 24 | 8.4% | 96.3% | ||
| Q2 24 | 7.7% | 19.0% | ||
| Q1 24 | 9.0% | 0.8% |
每股收益（稀释后）ATLCPRPRX
| Q4 25 | $1.75 | $0.49 | ||
| Q3 25 | $1.21 | $0.67 | ||
| Q2 25 | $1.51 | $0.07 | ||
| Q1 25 | $1.49 | $0.55 | ||
| Q4 24 | $1.42 | $0.46 | ||
| Q3 24 | $1.27 | $1.21 | ||
| Q2 24 | $0.99 | $0.23 | ||
| Q1 24 | $1.09 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $621.1M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $608.7M | $9.7B |
| 总资产 | $7.6B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资ATLCPRPRX
| Q4 25 | $621.1M | $618.7M | ||
| Q3 25 | $425.0M | $938.9M | ||
| Q2 25 | $329.4M | $631.9M | ||
| Q1 25 | $350.4M | $1.1B | ||
| Q4 24 | $375.4M | $929.0M | ||
| Q3 24 | $308.7M | $950.1M | ||
| Q2 24 | $350.9M | $1.8B | ||
| Q1 24 | $444.8M | $843.0M |
总债务ATLCPRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益ATLCPRPRX
| Q4 25 | $608.7M | $9.7B | ||
| Q3 25 | $589.3M | $9.6B | ||
| Q2 25 | $563.3M | $9.5B | ||
| Q1 25 | $532.7M | $9.8B | ||
| Q4 24 | $492.9M | $10.3B | ||
| Q3 24 | $457.7M | $10.3B | ||
| Q2 24 | $433.8M | $9.8B | ||
| Q1 24 | $416.0M | $9.9B |
总资产ATLCPRPRX
| Q4 25 | $7.6B | $19.6B | ||
| Q3 25 | $7.1B | $19.3B | ||
| Q2 25 | $3.6B | $18.3B | ||
| Q1 25 | $3.3B | $17.6B | ||
| Q4 24 | $3.3B | $18.2B | ||
| Q3 24 | $3.0B | $18.0B | ||
| Q2 24 | $2.8B | $17.7B | ||
| Q1 24 | $2.8B | $16.1B |
负债/权益比ATLCPRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $266.3M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 7.69× | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ATLCPRPRX
| Q4 25 | $266.3M | $827.1M | ||
| Q3 25 | $107.5M | $702.6M | ||
| Q2 25 | $132.7M | $364.0M | ||
| Q1 25 | $131.6M | $596.1M | ||
| Q4 24 | $122.6M | $742.5M | ||
| Q3 24 | $112.4M | $703.6M | ||
| Q2 24 | $115.6M | $658.2M | ||
| Q1 24 | $118.8M | $664.6M |
现金转化率ATLCPRPRX
| Q4 25 | 7.69× | 3.86× | ||
| Q3 25 | 4.30× | 2.44× | ||
| Q2 25 | 4.34× | 12.06× | ||
| Q1 25 | 4.17× | 2.50× | ||
| Q4 24 | 3.96× | 3.57× | ||
| Q3 24 | 3.80× | 1.29× | ||
| Q2 24 | 4.76× | 6.45× | ||
| Q1 24 | 4.54× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATLCP
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
